ALX ONCOLOGY HOLDINGS INC - ALXO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 06, 2026 | SVP, FINANCE AND CAO | S | D | 1,404.0 | 2.04 | 2,864.16 | 88,401.0 | View | |
| Apr 17, 2026 | Chief Dev & Operating Officer | A | A | 800,000.0 | 0.0 | 0.0 | 800,000.0 | View | |
| Apr 17, 2026 | Chief Medical Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Mar 23, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 12,311.0 | 2.17 | 26,714.87 | 293,609.0 | View | |
| Mar 23, 2026 | SVP, FINANCE AND CAO | S | D | 903.0 | 2.17 | 1,959.51 | 86,805.0 | View | |
| Mar 05, 2026 | Chief Medical Officer | A | A | 700,000.0 | 0.0 | 0.0 | 700,000.0 | View | |
| Feb 20, 2026 | SVP, FINANCE AND CAO | S | D | 565.0 | 2.27 | 1,282.55 | 87,708.0 | View | |
| Feb 19, 2026 | CHIEF EXECUTIVE OFFICER | F | D | 2,201.0 | 2.27 | 4,996.27 | 305,920.0 | View | |
| Feb 04, 2026 | — | P | A | 3,184,713.0 | 1.57 | 4,999,999.41 | 8,453,038.0 | View | |
| Jan 28, 2026 | SVP, FINANCE AND CAO | A | A | 192,000.0 | 0.0 | 0.0 | 192,000.0 | View | |
| Jan 28, 2026 | Chief Financial Officer | A | A | 303,000.0 | 0.0 | 0.0 | 303,000.0 | View | |
| Jan 28, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 912,000.0 | 0.0 | 0.0 | 912,000.0 | View |